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Response to letter by HJM Kerkhof on “Human genetic studies on osteoarthritis
from clinicians’ viewpoints”We greatly appreciate the in-depth discussion by Dr. Kerkhof
et al. on our editorial1. We also thank the authors for providing us
a chance to make the points clearer so that readers of the editorial
avoid misunderstanding our true intention. Our editorial referred
speciﬁcally to conventional low-quality studies and not to genetic
studies in general if they have been carried out to a high standard.
The question raised in our editorial is whether conventional osteo-
arthritis (OA) genetic studies in the past have been performed with
sufﬁcient scientiﬁc strictness. Unfortunately, there are many low-
quality studies in which inadequate effort has been paid to the
stringency of study design. The editorial stresses the importance
of the exactness of phenotype deﬁnition, selection of appropriate
controls, and adjustment for confounding factors for OA genetic
studies to discover true OA susceptibility genes. In fact, inconsistent
and ambiguous disease deﬁnition is a critical limitation of studies
as the authors indicate in their paper2. Use of controls such as
patients with other diseases than OA or so-called healthy subjects
without knee symptoms may yield misleading results since they
are likely to be contaminated by a substantial percentage of OA
subjects. Adjustment of age and other confounders of OA is impor-
tant, but even a prestigious journal in the genetic ﬁeld has not
seemed to take much account of age-matching between OA cases
and controls [Ref. 1, Table 1].
We agree with Kerkhof et al. that the issues concerning poor
study design hurt not only genetic studies but all OA studies.
However, it is still true that there are currently only a few loci
that have alleles demonstrating truly compelling association to
OA across a broad range of ethnic groups in spite of the enormous
investment in the OA genetic studies3. We sincerely hope that
recent introduction of regulations on study design with scientiﬁc
strictness such as now imposed on clinical trials4,5 will assure
that a genuine therapeutic target or prognostic marker of OA
worthy of the numerous efforts and great expense being made
will be reached.
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